Author:
Siddiqa Ayesha,Basharat Shahnai,Mubarik Fizza,Farooq Fatima,Ali Muhammad
Abstract
Cardiovascular-related diseases are considered as the major risk for health and may lead to many illnesses. Hyperlipidemia is the highest common cause of diseases related to heart known as CHD. Since ancient times, innumerable herbs and organic foods are used to treat diseases among which garlic has been shown beneficial for treating hyperlipidemia and normalizing lipid profile levels. Garlic may be used in different forms like powder, tablets, extracts or after ageing. Its sulfur containing compounds like allicin, S-allylcysteine, alliin, ajoene, diallyl disulfide are proven to have the pharmacological benefits. The main aim of the current review is to analyze and evaluate the studies regarding anti-hyperlipidemic effects of garlic and its supplements on normalizing lipid profile among hyperlipidemicsubjects.After analyzing different studies being carried out earlier, it is concluded that garlic is effective in managing lipid profile including total cholesterol, triglycerides, LDL, HDL levels among people with hyperlipidemia ranging from mild to moderate intensity.
Publisher
CrossLinks International Publishers
Reference64 articles.
1. 1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
2. 2. Casas R, Sacanella E, Urpí-Sardà M, Corella D, Castaner O, Lamuela-Raventos RM, et al. Long-term immunomodulatory effects of a mediterranean diet in adults at high risk of cardiovascular disease in the Preventión con DietaMediterránea (PREDIMED) randomized controlled trial. The Journal of nutrition. 2016 Sep 1;146(9):1684-93.
3. https://doi.org/10.3945/jn.115.229476
4. 3. Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927-946.
5. 4. Pencina MJ, Navar-Boggan AM, D'AgostinoSr RB, Williams K, Neely B, Sniderman AD, Peterson ED. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014 Apr 10;370:1422-31.